+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Estimation of time since infection using longitudinal disease-marker data

Statistics in Medicine 13(3): 231-244
Estimation of time since infection using longitudinal disease-marker data
We propose a method to estimate the usually unknown time since infection for individuals infected with human immunodeficiency virus type 1 (HIV-1). If we assume the time since infection has an exponential prior distribution, then under the model the conditional distribution of time since infection, given the CD4 level at the time of the first positive HIV-1 antibody test, is a truncated normal density. We applied the method to prevalent cohort data both from intravenous drug users and from homosexual/bisexual men. For the intravenous drug users the estimated mean time since infection was 15.0 months from infection at a presumed mean CD4 level of 1060 cells/ml to first positive antibody test at a CD4 level of 597 cells/ml, which was the average CD4 at enrolment for infected subjects. For the homosexual/bisexual men the estimated mean time since infection was 16.7 months from infection at a presumed mean CD4 level of 699 cells/ml to first positive antibody test at an average CD4 level of 577 cells/ml. We performed a validation study using initially seronegative subjects in these cohorts who seroconverted to HIV-1-positive antibody status during the follow-up period. For the intravenous drug users, data were too few to provide definitive verification of the method. In the cohort of homosexual/bisexual men, however, there was a total of 70 seroconverters with relevant data. Among them, the median absolute difference between the midpoint of the known seroconversion interval and the estimated mean infection date was 4.6 months, conditional on CD4-lymphocyte measurements taken approximately 18 months subsequent to infection. Conditional on CD4 approximately 30 months after infection, this median difference increased modestly to 8.2 months. Our analysis suggested that the underlying mathematical model tends to overestimate short times since infection and underestimate long times since infection. We consider potential corrective modifications to the model.

Accession: 002373501

PMID: 7911249

DOI: 10.1002/sim.4780130306

Download PDF Full Text: Estimation of time since infection using longitudinal disease-marker data

Related references

Semiparametric estimation of time-dependent ROC curves for longitudinal marker data. Biostatistics 5(4): 615-632, 2004

Estimation of growth curves from longitudinal data collected at irregular time intervals. Computers & Biomedical Research 19(6): 575-587, 1986

A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome. Statistics in Medicine 22(20): 3161-3175, 2003

The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure. Biostatistics 3(4): 547-563, 2003

Estimation of mean ruminal retention time of DNDF in dairy cows based on combined data from rumen evacuations and marker excretion curves. Journal of Dairy Science 86(Supplement 1): 341-342, 2003

A framework for the joint modeling of longitudinal diagnostic outcome data and latent infection status: application to investigating the temporal relationship between infection and disease. Biometrics 68(2): 371-379, 2012

Estimation of the infection time and latency distribution of AIDS with doubly censored data. Biometrics 50(1): 204-212, 1994

Estimation of the marker gene frequency and linkage disequilibrium from conditional marker data. American Journal of Human Genetics 36(1): 177-186, 1984

Semi-parametric estimation of age-time specific infection incidence from serial prevalence data. Statistics in Medicine 18(3): 307-320, Feb 15, 1999

Estimation of segregation and linkage parameters in simulated data. II. Simultaneous estimation with one linked marker. American Journal of Human Genetics 45(1): 95-105, 1989